Browsing Institutt for helse- og omsorgsvitskap by Author "Jenum, Anne Karen"
Now showing items 1-3 of 3
-
Cohort profile: Outcomes & Multi-morbidity In Type 2 diabetes (OMIT) – a national registry-based observational cohort with focus on care and treatment of key high-risk groups in Norway
Forster, Rachel Bedenis; Strandberg, Ragnhild Bjarkøy; Tibballs, Katrina Louise Bø; Nøkleby, Kjersti; Berg, Tore Julsrud; Iversen, Tor; Hagen, Terje P.; Richardsen, Kåre Rønn; Cooper, John; Sandberg, Sverre; Løvaas, Karianne Fjeld; Nilsen, Roy Miodini; Iversen, Marjolein M.; Jenum, Anne Karen; Buhl, Esben Selmer (Peer reviewed; Journal article, 2022)Purpose The ‘Outcomes & Multi-morbidity in Type 2 Diabetes’ (OMIT) is an observational registry-based cohort of Norwegian patients with type 2 diabetes (T2D) established to study high-risk groups often omitted from randomised ... -
Gestational diabetes mellitus by maternal country of birth and length of residence in immigrant women in Norway
Strandberg, Ragnhild Bjarkøy; Iversen, Marjolein M.; Jenum, Anne Karen; Sørbye, Linn Marie; Vik, Eline Skirnisdottir; Schytt, Erica; Aasheim, Vigdis; Nilsen, Roy Miodini (Peer reviewed; Journal article, 2020)Aims Immigrant women are at higher risk for gestational diabetes mellitus (GDM) than non‐immigrant women. This study described the prevalence of GDM in immigrant women by maternal country of birth and examined the ... -
How valid is a prescription-based multimorbidity index (Rx-risk) in predicting mortality in the Outcomes and Multimorbidity In Type 2 diabetes (OMIT) study? A nation-wide registry-based cohort study from Norway
Igland, Jannicke; Forster, Rachel Bedenis; Jenum, Anne Karen; Strandberg, Ragnhild Bjarkøy; Berg, Tore Julsrud; Røssberg, Jan Ivar; Iversen, Marjolein M.; Buhl, Esben Selmer (Peer reviewed; Journal article, 2024)Objective The prescription-based Rx-risk index has previously been developed to measure multimorbidity. We aimed to adapt and evaluate the validity of the Rx-risk index in prediction of mortality among persons with type 2 ...